{"slug":"foundation-medicine","name":"Foundation Medicine","ticker":null,"isPublic":false,"entityType":"unknown","ownership":"private","parentCompany":null,"parentSlug":null,"financials":null,"financialsByYear":null,"mentionedBy":[{"slug":"tempus-ai","name":"Tempus AI, Inc.","ticker":"TEM","year":2024,"notes":"Genomic profiling for cancer"},{"slug":"tempus-ai","name":"Tempus AI, Inc.","ticker":"TEM","year":2025,"notes":"Roche-owned genomic testing leader"}],"competitors":[],"notes":{"2024":[{"from":"Tempus AI, Inc.","note":"Genomic profiling for cancer"}],"2025":[{"from":"Tempus AI, Inc.","note":"Roche-owned genomic testing leader"}]}}